Allscripts (MDRX) Tops Q3 EPS by 5c; Withdrawing Guidance; to Evaluate Alternatives
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Tech stocks pull Wall Street lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Piper Jaffray Downgrades Allscripts (MDRX) to Underweight
November 9, 2012 6:54 AM ESTPiper Jaffray downgraded Allscripts (NASDAQ: MDRX) from Neutral to Underweight with a price target of $7.00 (from $12.00) following Q3 results and announcement that it will explore alternatives.
For an analyst ratings summary and ratings history on Allscripts... More
Allscripts-Misys (MDRX) Resumes, Shares Higher in Late Trading
November 8, 2012 4:40 PM ESTAllscripts-Misys Healthcare Solution (NASDAQ: MDRX) resumes trading with the stock up over 7 percent in the late session Thursday.... More
Allscripts-Misys Healthcare Solution (MDRX) halted, news pending
November 8, 2012 4:02 PM ESTAllscripts-Misys Healthcare Solution (NASDAQ: MDRX) halted, news pending... More
